NCT02008734View on ClinicalTrials.gov

Randomized Phase II Study to Assess PD 0332991 in Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Untreated Operable Early Breast Cancer
Interventions
DRUG

PD0332991

Trial Locations (1)

94805

Gustave Roussy, Villejuif

All Listed Sponsors
lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

NCT02008734 - Randomized Phase II Study to Assess PD 0332991 in Breast Cancer | Biotech Hunter | Biotech Hunter